This often results in a preference for conservative and traditional ... In most cases, such an approach should be avoided. Clip art is readily available, making the company seem less professional. It ...

MONMOUTH JUNCTION, N.J.--(BUSINESS WIRE)--Tris Pharma, Inc. (Tris), a commercial-stage biopharmaceutical company, today announced positive topline results from its ALLEVIATE-2 Phase 3 pivotal ...

According to the survey results, 85% of staff said that they ... According to the district, that was a 5.4% increase in positive responses over last year's survey. Additionally, 93% of respondents ...

Management reported positive results, and included examples of AI monetization opportunities, providing some justification for its capital spending over recent periods. There was also some ...

today announced positive results from the clinical study of its AI-powered HYLA™ blood sensor. Inspira believes that these breakthrough results strengthen the Company's progress in developing ...

--(BUSINESS WIRE)--Protagonist Therapeutics, Inc. (“Protagonist”) (NASDAQ:PTGX) and Takeda (TSE:4502/NYSE:TAK) today announced positive topline results for the Phase 3 VERIFY study, in which ...

In Geneva we will do everything possible to achieve a positive result, President Nikos Christodoulides said on Sunday referring to an enlarged meeting there later this month on Cyprus talks.

Under the license and collaboration agreement between Protagonist and Takeda, Protagonist earns a $25 million milestone payment following these positive results. The milestone is payable following ...

There has been a noticeably positive atmosphere around West Ham United since Graham ... and competitive home derbies with Fulham and Crystal Palace have not yielded the results the Hammers’ displays ...

“The hard work I have put in, especially in the last one year, is really paying off,” says B. Rithvik Choudhary, who partnered Nicolas Barrientos of Colombia to clinch the ATP Santiago title ...

Pfizer and Astellas Pharma have shared positive results from a late-stage study of their antibody-drug conjugate Padcev (enfortumab vedotin-ejfv) in bladder cancer. The phase 3 EV-302 trial, also ...